Nepedia
Back to Discover
Advanced Reader
🧬

Diabetes medication

life science Maturity 5-7 Next article →

Diabetes medications are drugs used to treat diabetes mellitus. This condition is characterized by high levels of glucose, or sugar, in the bloodstream. Managing these levels is vital because chronic hyperglycemia can lead to serious organ damage. This damage can affect the kidneys, the heart, and the nervous system.

Incretins and DPP 4 inhibitors
Incretins and DPP 4 inhibitors

Different medications are chosen based on the type of diabetes. Doctors consider the patient's age and their specific health situation. Some drugs are given as injections, while others are taken as pills. These pills are often called oral hypoglycemic agents.

To understand these drugs, we must look at how they work. There are four main mechanisms of action used to lower blood sugar. First, insulin sensitizers help cells respond better to insulin. This reduces insulin resistance, which is a major issue in Type 2 diabetes. Second, secretagogues stimulate the beta cells in the pancreas. These cells are responsible for secreting insulin into the blood.

Third, some drugs act as enzyme inhibitors. Alpha-glucosidase inhibitors slow down how fast the body absorbs glucose from the gut. Alpha-amylase inhibitors work similarly by slowing the digestion of starch. Finally, SGLT2 inhibitors target the kidneys. They prevent the renal tubules from reabsorbing glucose, so the sugar is removed through urination.

Type 1 and Type 2 diabetes require very different approaches. Type 1 diabetes is an autoimmune disorder. In this condition, the body's immune system destroys the insulin-secreting beta cells in the pancreas. Because these cells are gone, the body cannot make insulin. Therefore, people with Type 1 diabetes must use regular insulin injections or an insulin pump.

Type 2 diabetes is much more common. It occurs when cells develop insulin resistance. This means the cells do not use insulin properly. The pancreas tries to compensate by making even more insulin. Eventually, the pancreas cannot keep up, and blood sugar levels rise.

Insulin itself comes in many different forms. These forms are categorized by how quickly they work and how long they last. Rapid-acting insulins, such as insulin lispro, peak in about one hour. Short-acting insulins, like regular insulin, peak in two to four hours. Intermediate-acting options, such as NPH insulin, peak between four and ten hours. Long-acting insulins, like insulin glargine, can last for 24 hours. Some, like insulin degludec, are "ultra-long" acting and can last about 42 hours.

Most insulin is given subcutaneously, which means under the skin.

Specific classes of drugs target Type 2 diabetes in unique ways. Biguanides are a major class, and metformin is the most common biguanide used. Metformin is often the first-line treatment for children and teenagers. It works by reducing glucose output from the liver and increasing glucose uptake in muscles. It is unique because it is a widely used oral drug that does not cause weight gain. It can reduce glycated hemoglobin (A1C) values by 1.5% to 2.0%.

Another class is called thiazolidinediones, or TZDs. These drugs, such as pioglitazone, bind to a protein called PPARγ. This process helps regulate genes involved in glucose and fat metabolism.

Secretagogues are another important group of medications. Sulfonylureas were the first widely used oral drugs in this category. They work by inhibiting the KATP channel of the pancreatic beta cells. This inhibition triggers the pancreas to release more insulin. While they are very effective and low in cost, they can cause weight gain. They also carry a risk of hypoglycemia, which is low blood sugar. Because they rely on the body's own insulin production, they cannot be used to treat Type 1 diabetes.

Medical science is moving toward more complex treatment plans. As of 2020, the FDA had approved 23 unique combinations of antihyperglycemic drugs. Doctors often combine different classes to manage blood sugar more effectively. In 2019, the first triple combination of oral drugs was approved. This mixture included metformin, saxagliptin, and dapagliflozin. A second triple combination was approved in 2020. That combination used metformin, linagliptin, and empagliflozin.

These advancements allow for more precise control of the disease.

672 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (1)
File:Incretins and DPP 4 inhibitors.svg
Incretins and DPP 4 inhibitors.svg
More to explore

🔗 What's this?

Concepts mentioned in this article

✨ What else?

Related topics you might enjoy

🔬 Go deeper

More advanced topics to explore

🪜 Step back

Simpler topics to build understanding

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.